Oncology News

The protective effect of a single flexible sigmoidoscopy screening in older adults was maintained for up 15 years against colorectal cancer incidence and for up to 19 years against mortality, according to a randomized controlled trial.

In this video exclusive with Healio Gastroenterology, Swati G. Patel MD, MS, discussed the U.S. Multi-Society Task Force on Colorectal Cancer’s updated screening recommendations for colorectal cancer.

The FDA cleared an investigational new drug application for CYNK-101, a natural killer cell therapy for the treatment of patients with advanced HER2/neu-positive gastric or gastroesophageal junction adenocarcinoma.

The value of colonoscopy for colorectal cancer screening is important from the perspective of the business aspect and also patient care aspect, according to a speaker at GI Outlook.

The FDA granted fast track designation to arfolitixorin for treatment of patients with metastatic colorectal cancer.

The FDA granted orphan drug designation to toripalimab for the treatment of esophageal cancer.

The FDA granted orphan drug designation to DF1001 for treatment of esophageal cancer.

Use of a transforming growth factor-beta pathway-based combinatorial serum protein panel may aid in the early detection of hepatocellular carcinoma, according to research presented at The Liver Meeting Digital Experience.

The U.S. Multi-Society Task Force on Colorectal Cancer updated its screening recommendations.

Despite a significant amount of data in the adjuvant setting for pancreatic cancer, more research is needed to better define perioperative and neoadjuvant treatment strategies, according to a speaker at Chemotherapy Foundation Symposium.